{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibudxs2snylcvo5rvxj443anokrwnsokwi7h73ao3u26x6ued2cku",
    "uri": "at://did:plc:3ueatpf6zh5nibd6nd3pao4o/app.bsky.feed.post/3mnjatchlh6h2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidref7uabq64s7wb3olprc6oaejv3qh4prp3unn3z4q7ppt3tetoy"
    },
    "mimeType": "image/webp",
    "size": 682774
  },
  "path": "/newlimit-raises-435-million-age-reversing-medicine-human-trials/",
  "publishedAt": "2026-06-04T19:43:00.000Z",
  "site": "https://athletechnews.com",
  "tags": [
    "Finance",
    "Funding",
    "Longevity",
    "NewLimit"
  ],
  "textContent": "NewLimit has reaised $435M, led by Peter Thiel's Founders Fund, to bring an age-reversing medicine to human trial next year.",
  "title": "NewLimit Raises $435M for Age-Reversing Medicine"
}